Skip to main content
. Author manuscript; available in PMC: 2023 May 22.
Published in final edited form as: Am J Geriatr Psychiatry. 2020 Apr 13;29(1):66–77. doi: 10.1016/j.jagp.2020.03.018

Table 1.

Baseline Demographic and Clinical Characteristics of Depressed NCODE Participants Recruited Between 1998 and 2001 Who Did and Did Not Complete the NEO-PI-R.

Variable NEO-PI-R Completers (n=112) Refused NEO-PI-R (n=22) Not Approached with NEO-PI-R (n=114) Results of 3 group ANOVA / χ2 / Exact test
Age*** 67.8 (6.1) [59–83] 69.2 (7.3) [60–81] 72.4 (8.2) [59–91] Welch F(2.0,58.3) = 11.68, p <.0001
Education** 13.9 (2.7) [7–17] 13.0 (2.51) [7–17] 12.6 (2.9) [11–19] Welch F(2.0,62.9) = 5.06, p = .0092
Gender* 62% Female 68% Female 79% Female χ2 (2) = 8.16, p = 0.0169
Race* 89.3% White
4.5% Black
0.9% Asian
5.4% Other
86.4% White
14.0% Black
0% Asian
0% Other
76.3% White
16.7% Black
2.6% Asian
4.4%Other
Exact test, 0.0493
Marital Status ** 61.6% Married
3.6% Separated
17.0% Divorced
17.0% Widowed
0.9% Never married
50.0% Married
4.6% Separated
9.1% Divorced
31.8% Widowed
4.6% Never married
46.5% Married
3.5% Separated
7.9% Divorced
39.5% Widowed
2.6% Never married
Exact test, 0.0070
MMSE *** 28.2 (2.6) [11–30] 27.7 (2.0) [22–30] 26.6 (3.6) [9–30] F(2,245) = 8.63, p = 0.0002
NEO-PI-R T scores Mean (SD) [% > 55] - - -
Neuroticism 54.7 (11.7) [44%] - - -
Extraversion 45.2 (9.4) [13%] - - -
Openness 45.6 (11.4) [24%] - - -
Agreeableness 54.3 (9.2) [46%] - - -
Conscientiousness 43.9 (11.4) [18%] - - -
MADRS Total 26.9 (6.9) [13–50] 28.4 (9.3) [16–53] 28.6 (8.3) [10–52] F(2,245) = 1.41, p = 0.2453
Suicidal Ideation (% ≥ 2 on MADRS #10) 48.2% 36.4% 50.9% χ2 (2) = 1.56, p = 0.4589
History of Suicide Attempt 11.6% 0% 7.0% χ2 (2) = 3.77, p = 0.1519
Perceived Social Support (/30) 23.7 (3.8) [11–28] 22.3 (4.5) [12–28] 22.6 (4.2) [11–28] F(2,238) = 2.38, p = 0.0948

Note. Data are means, (standard deviation), and [range] unless otherwise noted; MADRS = Montgomery-Asberg Depression Rating Scale, MMSE = Mini-Mental State Exam.

*

p < .05,

**

p < .01

***

p < .001 post-hoc comparison of NEO-PI-R completers with those patients not approached with NEO-PI-R. Post-hoc comparisons did not reveal significant group differences between NEO-PI-R completers and those who refused NEO-PI-R, or between those who refused NEO-PI-R and those who were not approached with NEO-PI-R.